Centessa Pharmaceuticals PLC ADR (CNTA) — Cash Flow-to-Debt Ratio
Centessa Pharmaceuticals PLC ADR (CNTA) has a Cash Flow-to-Debt Ratio of -0.47x as of March 2026, meaning its operating cash flow of $-72.22 Million could theoretically repay 0% of its total liabilities ($154.41 Million) in one year. See working capital to net assets of Centessa Pharmaceuticals PLC ADR to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Centessa Pharmaceuticals PLC ADR Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Centessa Pharmaceuticals PLC ADR across 7 annual periods. Also explore Centessa Pharmaceuticals PLC ADR (CNTA) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Centessa Pharmaceuticals PLC ADR (2019–2025)
Year-by-year debt coverage analysis for Centessa Pharmaceuticals PLC ADR. For market capitalisation and broader financial context, see market value of Centessa Pharmaceuticals PLC ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.21x | $-193.82 Million | $160.63 Million | ▼ -48.9% |
| 2024 | -0.81x | $-142.06 Million | $175.25 Million | ▲ +37.3% |
| 2023 | -1.29x | $-160.34 Million | $124.00 Million | ▲ +30.3% |
| 2022 | -1.85x | $-200.55 Million | $108.14 Million | ▼ -88.1% |
| 2021 | -0.99x | $-136.14 Million | $138.08 Million | ▲ +20.1% |
| 2020 | -1.23x | $-10.63 Million | $8.62 Million | ▼ -28.4% |
| 2019 | -0.96x | $-5.83 Million | $6.07 Million | — |